C
CHRS//CIK 0001512762
Coherus Oncology, Inc.
Market Data
$1.67−$0.84 (−33.47%)
CHRS · Last trade
Prev Close
$2.51
Range (30d)
$1.61 – $2.33
Recent Filings
- 8-K563.8 KBCoherus Oncology, Inc.Feb 17, 4:05 PM ET·0001104659-26-016378
- 8-K156.5 KBCoherus Oncology, Inc.Feb 4, 8:40 AM ET·0001104659-26-010065
- 8-K231.3 KBCoherus Oncology, Inc.Jan 23, 5:27 PM ET·0001104659-26-006307
- 8-K790.2 KBCoherus Oncology, Inc.Jan 13, 9:00 AM ET·0001104659-26-003117
- 8-K16.5 MBCoherus Oncology, Inc.Nov 13, 5:13 PM ET·0001104659-25-111484
- 10-Q11.0 MBCoherus Oncology, Inc.Nov 6, 5:12 PM ET·0001104659-25-107852
- 8-K533.7 KBCoherus Oncology, Inc.Nov 6, 4:28 PM ET·0001104659-25-107780
- 8-K158.2 KBCoherus Oncology, Inc.Sep 8, 9:54 AM ET·0001558370-25-011911
- 10-Q11.4 MBCoherus Oncology, Inc.Aug 7, 4:55 PM ET·0001558370-25-010803
- 8-K548.0 KBCoherus Oncology, Inc.Aug 7, 4:53 PM ET·0001558370-25-010802
Insiders
10- Anicetti Vincent RChief, Quality & Compliance
- Daiichi Sankyo Company, LTDFormer 10% Owner
- ELI LILLY & Co10% Owner
- Erbez GeorgiaDirector
- FINCK BARBARA KChief Medical Officer
- FMR LLC10% Owner, See Remark 1
- HEALY JAMESDirector
- Herman Alan C.Chief Scientific Officer
- HORTON DARLENE PSee Remarks
- Karachun Rita ADirector
Tickers
Addresses
business
C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600
REDWOOD CITY, CA, 94065
mailing
C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600
REDWOOD CITY, CA, 94065
Former Names
- Coherus BioSciences, Inc.2025-05-28
- BioGenerics, Inc.2012-01-03